CVS Health Corporation
CVS Health Corporation（CVS）股东结构
基于 13F 申报与流通股数据，展示机构、内部人与公众持股结构；下方为前十大机构、机构动向与内部人交易。
SEC 13F · FMP · CVS · 截至 2025年3月31日
股东结构概览
1,845
机构持有人数
▲ 81 vs Q4
$73.35B
机构持仓总市值
▲ $26.32B vs Q4
1.28B
总流通股
freeFloat 99.79%
1.08B
13F 申报持股数
▲ 35.54M vs Q4
机构持仓% = 13F 持股数 ÷ 总流通股。内部人% = 100 − 自由流通率。散户% = 自由流通率 − 机构%。数据来源：FMP /symbol-positions-summary + /shares-float + SEC EDGAR。
前10大机构持仓
CVS 最大股东 · 机构持仓
Q1 2025 · SEC 13F
显示前 10 家
| 机构 | 持股数 | 占比 | 权重 | 市值 | 申报日 | 变动 |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC retail-drug stores and proprietary stores | 118.34M | 9.38% | 9.38% | $8.02T | May 9, 2025 | ▲ 969.0K |
BLACKROCK, INC. retail-drug stores and proprietary stores | 112.59M | 8.93% | 8.93% | $7.63T | May 2, 2025 | ▲ 6.63M |
DODGE & COX retail-drug stores and proprietary stores | 73.46M | 5.83% | 5.83% | $4.98T | May 14, 2025 | ▲ 3.35M |
CAPITAL WORLD INVESTORS retail-drug stores and proprietary stores | 68.40M | 5.42% | 5.42% | $4.63T | May 12, 2025 | ▲ 7.36M |
STATE STREET CORP retail-drug stores and proprietary stores | 57.99M | 4.60% | 4.60% | $3.93T | May 15, 2025 | ▲ 1.04M |
FMR LLC retail-drug stores and proprietary stores | 30.89M | 2.45% | 2.45% | $2.09T | May 12, 2025 | ▲ 2.76M |
GEODE CAPITAL MANAGEMENT, LLC retail-drug stores and proprietary stores | 27.96M | 2.22% | 2.22% | $1.89T | May 13, 2025 | ▲ 907.9K |
CAPITAL INTERNATIONAL INVESTORS retail-drug stores and proprietary stores | 26.19M | 2.08% | 2.08% | $1.77T | May 12, 2025 | ▼ 478.7K |
JPMORGAN CHASE & CO retail-drug stores and proprietary stores | 23.44M | 1.86% | 1.86% | $1.59T | May 12, 2025 | ▲ 9.54M |
INVESCO LTD. retail-drug stores and proprietary stores | 20.41M | 1.62% | 1.62% | $1.38T | May 12, 2025 | ▲ 2.38M |
数据来源：SEC 13F 申报文件。变动标识：isNew / isSoldOut / changeInSharesNumber。
机构仓位变动
Q1 2025 对比上季度
Q1 2025
30
增持
+79.36M 股0
新建仓
首次建仓19
减持
−25.61M 股0
清仓
完全退出净股数变化（前50家）
+53.76M
+79.36M / −25.61M
净新增持仓人
+11
新建 0 个 / 退出 0 个
基于前50家最大机构持仓统计，全市场实际数量可能不同。
内幕交易买卖情绪
CVS 内幕交易记录
数据来源：SEC Form 4
近期内部人员以卖出为主。 卖出可能源于预定的 10b5-1 计划，不代表负面展望。
12
买入笔数
20
卖出笔数
0.60
买卖比
$4M
卖出总金额
最近内幕交易记录
最近10条 · 仅普通股
| 姓名 · 职位 | 日期 | 类型 | 股数 | 价格 | 金额 | 交易后持股 | 申报 |
|---|---|---|---|---|---|---|---|
Newman Brian EVP, Chief Financial Officer | May 31, 2026 | Tax Withhold | 2,478 | $90.98 | $225.4K | 3.0K | Form 4 ↗ |
Compton-Phillips Amy EVP, Chief Medical Officer | May 31, 2026 | Tax Withhold | 7,618 | $90.98 | $693.1K | 9.6K | Form 4 ↗ |
AGUIRRE FERNANDO director | May 20, 2026 | D-Return | 30,437 | $93.78 | $2.85M | 12.1K | Form 4 ↗ |
AGUIRRE FERNANDO director | May 21, 2026 | D-Return | 1,563 | $93.50 | $146.1K | 10.5K | Form 4 ↗ |
ROBBINS LARRY director | May 19, 2026 | Sale | 1,983,387 | $94.45 | $187.33M | 6.21M | Form 4 ↗ |
ROBBINS LARRY director | May 19, 2026 | Sale | 151 | $95.18 | $14.4K | 6.21M | Form 4 ↗ |
ROBBINS LARRY director | May 20, 2026 | Sale | 797,628 | $93.48 | $74.56M | 5.42M | Form 4 ↗ |
ROBBINS LARRY director | May 20, 2026 | Sale | 152,691 | $94.81 | $14.48M | 5.26M | Form 4 ↗ |
ROBBINS LARRY director | May 20, 2026 | Sale | 66,881 | $95.67 | $6.40M | 5.20M | Form 4 ↗ |
ROBBINS LARRY director | May 20, 2026 | Sale | 800 | $96.28 | $77.0K | 5.20M | Form 4 ↗ |
数据来源：SEC Form 4。买卖方向：acquisitionOrDisposition A=买入，D=卖出。已排除 RSU 归属（M-Exempt）。
关于机构与内部人持股结构
CVS Health Corporation（CVS）主要由机构投资者持有，机构持股比例约为 84.9%。公司内部人员持股约 0.21%，散户及公众持股约占剩余的 14.94%。
CVS Health Corporation 最大机构股东为 VANGUARD GROUP INC，截至 March 31, 2025 持有约 118.34 million 股，占总流通股的 9.38%。
目前共有 1,845 家机构持有 CVS 股票，合计持仓市值约 $73.35 billion，数据来源为最新 SEC 13F 申报。
常见问题
CVS ownershipCVS Health Corporation（CVS）主要由机构投资者持有，机构持股约 84.9%。最大股东为 VANGUARD GROUP INC，持股比例 9.38%。内部人员持股约 0.21%。数据来源 SEC Form 13F，截至 March 31, 2025。